Digest Network Come funziona
Network
/
Società
Co
Non verificato

Cognito Therapeutics

Di cosa scriviamo

IndustriaMedicina - VarieSaluteScienzaVetrine/Shopping

18 comunicati stampa

Guarda tutti i comunicati
03/12/2025
Cognito Therapeutics Announces Presentation of New CSF Proteomic and EEG Biomarker Data for Spectris™ in Alzheimer’s Disease at CTAD 2025
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
18/11/2025
Software
Scienza
Hardware informatico
Vetrine/Shopping
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Terza età
Salute
Eventi
Industria
Cognito Therapeutics to Present New Biomarker Data for Spectris™ in Alzheimer’s Disease at CTAD 2025
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
13/11/2025
WVU Rockefeller Neuroscience Institute and Cognito Therapeutics Launch Brain Health Collaboratory to Accelerate Neurotherapies with AI-powered Research
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
28/07/2025
Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease at AAIC 2025
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
17/07/2025
Eventi
Industria
Terza età
Biotecnologia
Salute
Attrezzature medico-sanitarie
Vetrine/Shopping
Medicina - Varie
Cognito Therapeutics to Present Five Abstracts at AAIC 2025 Highlighting Spectris™ Treatment in Alzheimer’s Disease
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
01/07/2025
Salute
Attrezzature medico-sanitarie
Sanità
Medicina - Varie
Scienza
Industria
Cognito Therapeutics Completes Enrollment in HOPE Pivotal Study of Spectris™ AD Therapy for the Treatment of Patients with Alzheimer’s Disease
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
11/06/2025
Cognito Therapeutics Announces Non-invasive Neuromodulation Therapy Delays Alzheimer’s Disease Progression
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
02/04/2025
Cognito Therapeutics Announces Spectris™ Data Demonstrating Brain Structural Maintenance and Mechanism of Action in Alzheimer’s Disease at AD/PD™ 2025
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
25/03/2025
Eventi
Industria
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Software
Biotecnologia
Hardware informatico
Salute
Cognito Therapeutics to Present New Data on Spectris’™ Impact on Brain Structure in Alzheimer’s Disease at AD/PD 2025
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
12/02/2025
Cognito Therapeutics Strengthens Executive Team to Drive Next Phase of Growth and Commercialization
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0